ABVX ABIVAX SA More: the full row for ABIVAX SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 521,612 shares; 2024Q4: 1,513,393 shares; 2025Q1: 2,210,019 shares; 2025Q2: 3,071,340 shares; 2025Q3: 1,350,826 shares; 2025Q4: 1,317,329 shares; 2026Q1: 1,394,019 shares 1,394,019 $155M 9.33% +76,690 Timeline PTGX PROTAGONIST THERAPEUTICS INC More: the full row for PROTAGONIST THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 981,295 shares; 2024Q4: 1,020,333 shares; 2025Q1: 939,669 shares; 2025Q2: 948,069 shares; 2025Q3: 989,182 shares; 2025Q4: 1,049,168 shares; 2026Q1: 994,119 shares 994,119 $105M 6.3% -55,049 Timeline ROIV ROIVANT SCIENCES LTD More: the full row for ROIVANT SCIENCES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,025,450 shares; 2024Q4: 3,508,694 shares; 2025Q1: 3,483,404 shares; 2025Q2: 1,940,797 shares; 2025Q3: 3,347,501 shares; 2025Q4: 3,428,962 shares; 2026Q1: 3,285,906 shares 3,285,906 $91M 5.47% -143,056 Timeline IMVT IMMUNOVANT INC More: the full row for IMMUNOVANT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,131,707 shares; 2024Q4: 787,478 shares; 2025Q1: 968,866 shares; 2025Q2: 535,066 shares; 2025Q3: 2,241,753 shares; 2025Q4: 2,480,968 shares; 2026Q1: 2,679,010 shares 2,679,010 $66.5M 4% +198,042 Timeline SPY STATE STR SPDR S&P 500 ETF T More: the full row for STATE STR SPDR S&P 500 ETF T Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,684 shares; 2025Q3: 54,684 shares; 2025Q4: 54,684 shares; 2026Q1: 75,940 shares 75,940 $49.4M 2.97% +21,256 Timeline TERN TERNS PHARMACEUTICALS INC More: the full row for TERNS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 24,702 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 28,415 shares; 2025Q3: 10,000 shares; 2025Q4: 541,615 shares; 2026Q1: 914,699 shares 914,699 $48.2M 2.9% +373,084 Timeline CYTK CYTOKINETICS INC More: the full row for CYTOKINETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 911,182 shares; 2024Q4: 414,209 shares; 2025Q1: 390,729 shares; 2025Q2: 582,147 shares; 2025Q3: 518,921 shares; 2025Q4: 540,166 shares; 2026Q1: 632,556 shares 632,556 $41.7M 2.51% +92,390 Timeline CRNX CRINETICS PHARMACEUTICALS IN More: the full row for CRINETICS PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 88,425 shares; 2024Q4: 53,125 shares; 2025Q1: 53,125 shares; 2025Q2: 53,125 shares; 2025Q3: 248,368 shares; 2025Q4: 309,368 shares; 2026Q1: 1,139,331 shares 1,139,331 $41.4M 2.49% +829,963 Timeline BOXX EA SERIES TRUST More: the full row for EA SERIES TRUST Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 323,382 shares; 2024Q4: 325,450 shares; 2025Q1: 337,125 shares; 2025Q2: 337,125 shares; 2025Q3: 337,125 shares; 2025Q4: 337,125 shares; 2026Q1: 337,125 shares 337,125 $39.2M 2.36% 0 Timeline DNLI DENALI THERAPEUTICS INC More: the full row for DENALI THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 101,826 shares; 2024Q4: 44,826 shares; 2025Q1: 13,873 shares; 2025Q2: 35,716 shares; 2025Q3: 51,516 shares; 2025Q4: 52,116 shares; 2026Q1: 1,871,455 shares 1,871,455 $35.9M 2.16% +1,819,339 Timeline BEAM BEAM THERAPEUTICS INC More: the full row for BEAM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 43,900 shares; 2024Q4: 38,312 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,446,375 shares 1,446,375 $34.5M 2.07% new Timeline ZLAB ZAI LAB LTD More: the full row for ZAI LAB LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 532,454 shares; 2024Q4: 1,045,837 shares; 2025Q1: 940,858 shares; 2025Q2: 850,437 shares; 2025Q3: 868,780 shares; 2025Q4: 1,246,520 shares; 2026Q1: 1,425,367 shares 1,425,367 $26.8M 1.61% +178,847 Timeline SEPN SEPTERNA INC More: the full row for SEPTERNA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 720,848 shares; 2025Q2: 847,227 shares; 2025Q3: 1,176,491 shares; 2025Q4: 1,157,611 shares; 2026Q1: 1,089,818 shares 1,089,818 $26.2M 1.57% -67,793 Timeline VIR VIR BIOTECHNOLOGY INC More: the full row for VIR BIOTECHNOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 319,185 shares; 2024Q4: 64,067 shares; 2025Q1: 250,000 shares; 2025Q2: 250,000 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,744,714 shares 2,744,714 $24.6M 1.48% new Timeline DBVT DBV TECHNOLOGIES S A More: the full row for DBV TECHNOLOGIES S A Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,012,866 shares 1,012,866 $21.2M 1.27% new Timeline AVR ANTERIS TECHNOLOGIES GLOBAL More: the full row for ANTERIS TECHNOLOGIES GLOBAL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,052,968 shares; 2025Q1: 1,678,063 shares; 2025Q2: 531,515 shares; 2025Q3: 197,615 shares; 2025Q4: 1,238,777 shares; 2026Q1: 3,789,132 shares 3,789,132 $21M 1.26% +2,550,355 Timeline INSP INSPIRE MED SYS INC More: the full row for INSPIRE MED SYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,000 shares; 2025Q4: 15,000 shares; 2026Q1: 405,197 shares 405,197 $20.9M 1.26% +390,197 Timeline SRRK SCHOLAR ROCK HLDG CORP More: the full row for SCHOLAR ROCK HLDG CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 12,000 shares; 2024Q4: 19,505 shares; 2025Q1: 157,079 shares; 2025Q2: 39,677 shares; 2025Q3: 20,087 shares; 2025Q4: 69,589 shares; 2026Q1: 407,273 shares 407,273 $20M 1.2% +337,684 Timeline RYTM RHYTHM PHARMACEUTICALS INC More: the full row for RHYTHM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 30,941 shares; 2025Q1: 36,890 shares; 2025Q2: 45,390 shares; 2025Q3: 49,571 shares; 2025Q4: 51,349 shares; 2026Q1: 211,450 shares 211,450 $18.4M 1.11% +160,101 Timeline SYRE SPYRE THERAPEUTICS INC More: the full row for SPYRE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 12,560 shares; 2024Q4: not reported; 2025Q1: 15,033 shares; 2025Q2: 34,051 shares; 2025Q3: 34,051 shares; 2025Q4: 34,051 shares; 2026Q1: 338,323 shares 338,323 $17.1M 1.03% +304,272 Timeline CTMX CYTOMX THERAPEUTICS INC. More: the full row for CYTOMX THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 903,959 shares; 2024Q4: 145,036 shares; 2025Q1: 47,036 shares; 2025Q2: 3,081,414 shares; 2025Q3: 4,045,414 shares; 2025Q4: 4,182,769 shares; 2026Q1: 3,410,190 shares 3,410,190 $16M 0.96% -772,579 Timeline PRTA PROTHENA CORP PLC More: the full row for PROTHENA CORP PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 3,375,009 shares; 2025Q3: 1,469,098 shares; 2025Q4: 1,457,764 shares; 2026Q1: 1,581,443 shares 1,581,443 $15.4M 0.92% +123,679 Timeline SNY SANOFI SA More: the full row for SANOFI SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 99,600 shares; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 74,212 shares; 2025Q4: 63,474 shares; 2026Q1: 316,939 shares 316,939 $15.3M 0.92% +253,465 Timeline PCVX VAXCYTE INC More: the full row for VAXCYTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 10,097 shares; 2024Q4: not reported; 2025Q1: 12,800 shares; 2025Q2: 98,032 shares; 2025Q3: 213,064 shares; 2025Q4: 315,642 shares; 2026Q1: 259,137 shares 259,137 $15.1M 0.9% -56,505 Timeline MNPR MONOPAR THERAPEUTICS INC More: the full row for MONOPAR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 130,037 shares; 2025Q1: 100,774 shares; 2025Q2: 100,974 shares; 2025Q3: 129,999 shares; 2025Q4: 233,908 shares; 2026Q1: 264,278 shares 264,278 $14.5M 0.87% +30,370 Timeline ABUS ARBUTUS BIOPHARMA CORP More: the full row for ARBUTUS BIOPHARMA CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,089,321 shares; 2024Q4: 1,554,802 shares; 2025Q1: 1,879,114 shares; 2025Q2: 2,825,773 shares; 2025Q3: 2,903,226 shares; 2025Q4: 5,415,109 shares; 2026Q1: 3,133,175 shares 3,133,175 $14.1M 0.85% -2,281,934 Timeline AMLX AMYLYX PHARMACEUTICALS INC More: the full row for AMYLYX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 220,906 shares; 2024Q4: not reported; 2025Q1: 1,471,587 shares; 2025Q2: 1,205,101 shares; 2025Q3: 866,202 shares; 2025Q4: 890,356 shares; 2026Q1: 1,000,604 shares 1,000,604 $13.9M 0.84% +110,248 Timeline CLDX CELLDEX THERAPEUTICS INC NEW More: the full row for CELLDEX THERAPEUTICS INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 5,000 shares; 2024Q4: not reported; 2025Q1: 14,600 shares; 2025Q2: 57,466 shares; 2025Q3: 109,442 shares; 2025Q4: 646,767 shares; 2026Q1: 427,816 shares 427,816 $13.6M 0.82% -218,951 Timeline TSHA TAYSHA GENE THERAPIES INC More: the full row for TAYSHA GENE THERAPIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 251,400 shares; 2024Q4: 177,707 shares; 2025Q1: 1,066,309 shares; 2025Q2: 3,009,870 shares; 2025Q3: 2,835,680 shares; 2025Q4: 2,495,809 shares; 2026Q1: 2,979,429 shares 2,979,429 $13.3M 0.8% +483,620 Timeline XENE XENON PHARMACEUTICALS INC More: the full row for XENON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 27,903 shares; 2024Q4: 50,547 shares; 2025Q1: 127,548 shares; 2025Q2: 259,503 shares; 2025Q3: 189,098 shares; 2025Q4: 203,969 shares; 2026Q1: 228,899 shares 228,899 $13.3M 0.8% +24,930 Timeline STRO SUTRO BIOPHARMA INC More: the full row for SUTRO BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 67,077 shares; 2026Q1: 524,441 shares 524,441 $13.1M 0.79% +457,364 Timeline RVMD REVOLUTION MEDICINES INC More: the full row for REVOLUTION MEDICINES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 44,351 shares; 2024Q4: 170,000 shares; 2025Q1: 177,136 shares; 2025Q2: 134,136 shares; 2025Q3: 139,136 shares; 2025Q4: 145,079 shares; 2026Q1: 133,893 shares 133,893 $13M 0.78% -11,186 Timeline ELVN ENLIVEN THERAPEUTICS INC More: the full row for ENLIVEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 329,540 shares 329,540 $12.9M 0.78% +299,540 Timeline CGON CG ONCOLOGY INC More: the full row for CG ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 143,104 shares; 2024Q4: 215,750 shares; 2025Q1: 301,134 shares; 2025Q2: 523,216 shares; 2025Q3: 248,917 shares; 2025Q4: 258,139 shares; 2026Q1: 185,699 shares 185,699 $12.6M 0.76% -72,440 Timeline BIL SPDR SERIES TRUST More: the full row for SPDR SERIES TRUST Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 21,786 shares; 2024Q4: 131,786 shares; 2025Q1: 135,585 shares; 2025Q2: 135,585 shares; 2025Q3: 135,585 shares; 2025Q4: 135,585 shares; 2026Q1: 135,585 shares 135,585 $12.4M 0.75% 0 Timeline ESTA ESTABLISHMENT LABS HLDGS INC More: the full row for ESTABLISHMENT LABS HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,000 shares; 2024Q4: not reported; 2025Q1: 8,000 shares; 2025Q2: 25,000 shares; 2025Q3: 90,688 shares; 2025Q4: 171,422 shares; 2026Q1: 213,473 shares 213,473 $12.1M 0.73% +42,051 Timeline REPL REPLIMUNE GROUP INC More: the full row for REPLIMUNE GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,400 shares; 2025Q3: 978,894 shares; 2025Q4: 1,241,322 shares; 2026Q1: 1,582,987 shares 1,582,987 $12.1M 0.73% +341,665 Timeline IVA INVENTIVA SA More: the full row for INVENTIVA SA Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,709,846 shares; 2026Q1: 2,174,398 shares 2,174,398 $12.1M 0.73% -535,448 Timeline IONS IONIS PHARMACEUTICALS INC More: the full row for IONIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 700 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 148,461 shares; 2025Q3: 133,818 shares; 2025Q4: 147,130 shares; 2026Q1: 160,338 shares 160,338 $12M 0.72% +13,208 Timeline NKTR NEKTAR THERAPEUTICS More: the full row for NEKTAR THERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 15,796 shares; 2025Q3: 72,007 shares; 2025Q4: 72,031 shares; 2026Q1: 161,252 shares 161,252 $11.6M 0.7% +89,221 Timeline IKT INHIBIKASE THERAPEUTICS INC More: the full row for INHIBIKASE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 5,103,005 shares; 2025Q1: 5,122,105 shares; 2025Q2: 5,122,105 shares; 2025Q3: 5,247,603 shares; 2025Q4: 8,063,949 shares; 2026Q1: 6,606,572 shares 6,606,572 $11.1M 0.67% -1,457,377 Timeline SPRY ARS PHARMACEUTICALS INC More: the full row for ARS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 59,230 shares; 2025Q4: 369,569 shares; 2026Q1: 1,361,536 shares 1,361,536 $10.9M 0.66% +991,967 Timeline HLXC HELIX ACQUISITION CORP III More: the full row for HELIX ACQUISITION CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,000,000 shares 1,000,000 $10.3M 0.62% new Timeline OVID OVID THERAPEUTICS INC More: the full row for OVID THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 37,743 shares; 2024Q4: 130,532 shares; 2025Q1: 115,867 shares; 2025Q2: 115,867 shares; 2025Q3: 12,846 shares; 2025Q4: 4,285,000 shares; 2026Q1: 4,544,113 shares 4,544,113 $10.1M 0.61% +259,113 Timeline OKUR ONKURE THERAPEUTICS INC More: the full row for ONKURE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: not reported; 2025Q4: 1,014,158 shares; 2026Q1: 2,434,941 shares 2,434,941 $10.1M 0.61% +1,420,783 Timeline REGN REGENERON PHARMACEUTICALS More: the full row for REGENERON PHARMACEUTICALS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 871 shares; 2024Q4: 1,361 shares; 2025Q1: 1,361 shares; 2025Q2: 3,361 shares; 2025Q3: 15,700 shares; 2025Q4: 12,051 shares; 2026Q1: 12,154 shares 12,154 $9.39M 0.56% +103 Timeline MLTX MOONLAKE IMMUNOTHERAPEUTICS More: the full row for MOONLAKE IMMUNOTHERAPEUTICS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 23,457 shares; 2024Q4: 17,424 shares; 2025Q1: 5,424 shares; 2025Q2: 34,314 shares; 2025Q3: 151,495 shares; 2025Q4: not reported; 2026Q1: 457,137 shares 457,137 $8.52M 0.51% new Timeline LXEO LEXEO THERAPEUTICS INC More: the full row for LEXEO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 57,166 shares; 2024Q4: 169,505 shares; 2025Q1: 170,448 shares; 2025Q2: 145,109 shares; 2025Q3: 1,531,953 shares; 2025Q4: 1,393,161 shares; 2026Q1: 1,467,350 shares 1,467,350 $8.42M 0.51% +74,189 Timeline IRD OPUS GENETICS INC More: the full row for OPUS GENETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 40,000 shares; 2026Q1: 1,849,004 shares 1,849,004 $8.41M 0.51% +1,809,004 Timeline TEVA TEVA PHARMACEUTICAL INDS LTD More: the full row for TEVA PHARMACEUTICAL INDS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 108,171 shares; 2024Q4: 146,671 shares; 2025Q1: 523,767 shares; 2025Q2: 345,878 shares; 2025Q3: 267,816 shares; 2025Q4: 235,971 shares; 2026Q1: 268,391 shares 268,391 $8.08M 0.49% +32,420 Timeline SVRA SAVARA INC More: the full row for SAVARA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 742,634 shares; 2024Q4: 988,468 shares; 2025Q1: 1,360,291 shares; 2025Q2: 3,600,670 shares; 2025Q3: 1,988,288 shares; 2025Q4: 1,405,452 shares; 2026Q1: 1,464,535 shares 1,464,535 $8M 0.48% +59,083 Timeline MPLT MAPLIGHT THERAPEUTICS INC More: the full row for MAPLIGHT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 374,909 shares 374,909 $7.62M 0.46% new Timeline LONA LEONABIO INC More: the full row for LEONABIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 393,701 shares; 2026Q1: 727,481 shares 727,481 $7.48M 0.45% +333,780 Timeline EQ EQUILLIUM INC More: the full row for EQUILLIUM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,318 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 5,559,988 shares; 2025Q4: 5,608,078 shares; 2026Q1: 3,726,659 shares 3,726,659 $7.45M 0.45% -1,881,419 Timeline VKTX VIKING THERAPEUTICS INC More: the full row for VIKING THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,100 shares; 2024Q4: 9,300 shares; 2025Q1: 59,413 shares; 2025Q2: 67,813 shares; 2025Q3: 175,919 shares; 2025Q4: 26,494 shares; 2026Q1: 227,717 shares 227,717 $7.41M 0.45% +201,223 Timeline DMRA DAMORA THERAPEUTICS INC More: the full row for DAMORA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 279,000 shares 279,000 $7.23M 0.43% new Timeline URGN UROGEN PHARMA LTD More: the full row for UROGEN PHARMA LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 35,000 shares; 2025Q4: 125,375 shares; 2026Q1: 395,459 shares 395,459 $7.11M 0.43% +270,084 Timeline BBIO BRIDGEBIO PHARMA INC More: the full row for BRIDGEBIO PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,448,470 shares; 2024Q4: 678,857 shares; 2025Q1: 339,635 shares; 2025Q2: 259,659 shares; 2025Q3: 273,414 shares; 2025Q4: 213,414 shares; 2026Q1: 94,292 shares 94,292 $7M 0.42% -119,122 Timeline PRME PRIME MEDICINE INC More: the full row for PRIME MEDICINE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,973,282 shares 1,973,282 $6.87M 0.41% new Timeline VRTX VERTEX PHARMACEUTICALS INC More: the full row for VERTEX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,000 shares; 2025Q4: 13,716 shares; 2026Q1: 15,075 shares 15,075 $6.73M 0.4% +1,359 Timeline KRRO KORRO BIO INC More: the full row for KORRO BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 49,451 shares; 2024Q4: 57,978 shares; 2025Q1: 68,715 shares; 2025Q2: 68,815 shares; 2025Q3: 40,235 shares; 2025Q4: not reported; 2026Q1: 540,054 shares 540,054 $6.11M 0.37% new Timeline VRDN VIRIDIAN THERAPEUTICS INC More: the full row for VIRIDIAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 9,206 shares; 2024Q4: 26,000 shares; 2025Q1: 79,000 shares; 2025Q2: 170,598 shares; 2025Q3: 101,704 shares; 2025Q4: 77,198 shares; 2026Q1: 304,422 shares 304,422 $5.95M 0.36% +227,224 Timeline DHR DANAHER CORP DEL More: the full row for DANAHER CORP DEL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 4,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 25,600 shares; 2026Q1: 30,932 shares 30,932 $5.86M 0.35% +5,332 Timeline INSM INSMED INC More: the full row for INSMED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,634 shares; 2024Q4: 21,974 shares; 2025Q1: 6,074 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 35,392 shares 35,392 $5.79M 0.35% new Timeline ASND ASCENDIS PHARMA A/S More: the full row for ASCENDIS PHARMA A/S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 161,402 shares; 2024Q4: 71,402 shares; 2025Q1: 1,402 shares; 2025Q2: 1,402 shares; 2025Q3: 36,345 shares; 2025Q4: 25,314 shares; 2026Q1: 25,014 shares 25,014 $5.72M 0.34% -300 Timeline BHF BRIGHTHOUSE FINL INC More: the full row for BRIGHTHOUSE FINL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 95,523 shares; 2026Q1: 95,523 shares 95,523 $5.72M 0.34% 0 Timeline SRPT SAREPTA THERAPEUTICS INC More: the full row for SAREPTA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 7,100 shares; 2024Q4: 40,002 shares; 2025Q1: 122,921 shares; 2025Q2: 210,313 shares; 2025Q3: 349,807 shares; 2025Q4: 28,866 shares; 2026Q1: 262,058 shares 262,058 $5.7M 0.34% +233,192 Timeline OACCU OAKTREE ACQUISITION CORP III More: the full row for OAKTREE ACQUISITION CORP III Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 500,000 shares; 2025Q1: 516,482 shares; 2025Q2: 516,482 shares; 2025Q3: 516,482 shares; 2025Q4: 516,482 shares; 2026Q1: 516,482 shares 516,482 $5.5M 0.33% 0 Timeline FRNM PERCEPTIVE CAP SOLUTIONS COR More: the full row for PERCEPTIVE CAP SOLUTIONS COR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 750,000 shares; 2024Q4: 750,000 shares; 2025Q1: 750,000 shares; 2025Q2: 750,000 shares; 2025Q3: 750,000 shares; 2025Q4: 456,720 shares; 2026Q1: 499,581 shares 499,581 $5.48M 0.33% +42,861 Timeline KRYS KRYSTAL BIOTECH INC More: the full row for KRYSTAL BIOTECH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 100 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,523 shares; 2025Q4: 20,014 shares; 2026Q1: 20,014 shares 20,014 $5.17M 0.31% 0 Timeline ABOS ACUMEN PHARMACEUTICALS INC More: the full row for ACUMEN PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 94,294 shares; 2025Q1: 146,183 shares; 2025Q2: 916,183 shares; 2025Q3: 891,183 shares; 2025Q4: 891,183 shares; 2026Q1: 2,156,334 shares 2,156,334 $5.09M 0.31% +1,265,151 Timeline IVVD INVIVYD INC More: the full row for INVIVYD INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 7,370,987 shares; 2025Q4: 3,899,397 shares; 2026Q1: 3,822,427 shares 3,822,427 $4.97M 0.3% -76,970 Timeline BHAVU BHAV ACQUISITION CORP More: the full row for BHAV ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 495,000 shares 495,000 $4.93M 0.3% new Timeline TARA PROTARA THERAPEUTICS INC More: the full row for PROTARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 122,690 shares; 2025Q1: 122,690 shares; 2025Q2: 122,690 shares; 2025Q3: 35,223 shares; 2025Q4: 1,136,799 shares; 2026Q1: 940,512 shares 940,512 $4.9M 0.29% -196,287 Timeline AGIO AGIOS PHARMACEUTICALS INC More: the full row for AGIOS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 21,300 shares; 2024Q4: not reported; 2025Q1: 27,900 shares; 2025Q2: 35,900 shares; 2025Q3: 37,000 shares; 2025Q4: 188,000 shares; 2026Q1: 140,672 shares 140,672 $4.76M 0.29% -47,328 Timeline LLY ELI LILLY & CO More: the full row for ELI LILLY & CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,150 shares; 2024Q4: 1,350 shares; 2025Q1: 600 shares; 2025Q2: 500 shares; 2025Q3: 1,000 shares; 2025Q4: not reported; 2026Q1: 5,060 shares 5,060 $4.65M 0.28% new Timeline DNTH DIANTHUS THERAPEUTICS INC More: the full row for DIANTHUS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 118,738 shares; 2024Q4: 17,683 shares; 2025Q1: 18,285 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 55,000 shares 55,000 $4.62M 0.28% new Timeline ARWR ARROWHEAD PHARMACEUTICALS IN More: the full row for ARROWHEAD PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 11,705 shares; 2024Q4: 12,900 shares; 2025Q1: 56,300 shares; 2025Q2: 55,200 shares; 2025Q3: 49,800 shares; 2025Q4: 58,200 shares; 2026Q1: 70,300 shares 70,300 $4.41M 0.26% +12,100 Timeline BLTE BELITE BIO INC More: the full row for BELITE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 39,839 shares; 2026Q1: 26,880 shares 26,880 $4.29M 0.26% -12,959 Timeline EVMN EVOMMUNE INC More: the full row for EVOMMUNE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 184,062 shares; 2026Q1: 184,062 shares 184,062 $4.23M 0.25% 0 Timeline MLYS MINERALYS THERAPEUTICS INC More: the full row for MINERALYS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 729,401 shares; 2024Q4: 841,541 shares; 2025Q1: 263,425 shares; 2025Q2: 302,125 shares; 2025Q3: 78,238 shares; 2025Q4: 136,231 shares; 2026Q1: 154,686 shares 154,686 $4.19M 0.25% +18,455 Timeline JANX JANUX THERAPEUTICS INC More: the full row for JANUX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 13,000 shares; 2024Q4: 31,509 shares; 2025Q1: 153,767 shares; 2025Q2: 62,088 shares; 2025Q3: 351,032 shares; 2025Q4: 245,452 shares; 2026Q1: 298,546 shares 298,546 $4.15M 0.25% +53,094 Timeline CLYM CLIMB BIO INC More: the full row for CLIMB BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 163,443 shares; 2024Q4: 48,125 shares; 2025Q1: 119,320 shares; 2025Q2: 119,320 shares; 2025Q3: 133,530 shares; 2025Q4: 1,432,475 shares; 2026Q1: 597,662 shares 597,662 $4.09M 0.25% -834,813 Timeline PALI PALISADE BIO INC More: the full row for PALISADE BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,004,845 shares; 2026Q1: 2,264,845 shares 2,264,845 $3.96M 0.24% +260,000 Timeline AEXA AMERICAN EXCEPTIONALISM ACQU More: the full row for AMERICAN EXCEPTIONALISM ACQU Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 357,539 shares; 2026Q1: 357,539 shares 357,539 $3.87M 0.23% 0 Timeline SPRB SPRUCE BIOSCIENCES INC More: the full row for SPRUCE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 58,000 shares; 2026Q1: 58,600 shares 58,600 $3.83M 0.23% +600 Timeline NAMS NEWAMSTERDAM PHARMA COMPANY More: the full row for NEWAMSTERDAM PHARMA COMPANY Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 112,359 shares; 2025Q3: 114,359 shares; 2025Q4: 118,623 shares; 2026Q1: 118,623 shares 118,623 $3.8M 0.23% 0 Timeline ZURA ZURA BIO LTD More: the full row for ZURA BIO LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,770,649 shares; 2024Q4: 2,077,251 shares; 2025Q1: 2,801,184 shares; 2025Q2: 997,547 shares; 2025Q3: 652,154 shares; 2025Q4: 562,065 shares; 2026Q1: 630,403 shares 630,403 $3.75M 0.23% +68,338 Timeline ACLX ARCELLX INC More: the full row for ARCELLX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,962 shares; 2024Q4: 3,962 shares; 2025Q1: 13,962 shares; 2025Q2: 13,962 shares; 2025Q3: 31,484 shares; 2025Q4: 31,484 shares; 2026Q1: 32,084 shares 32,084 $3.68M 0.22% +600 Timeline CTNM CONTINEUM THERAPEUTICS INC More: the full row for CONTINEUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 8,967 shares; 2024Q4: 82,234 shares; 2025Q1: 168,765 shares; 2025Q2: 166,799 shares; 2025Q3: 77,961 shares; 2025Q4: 278,961 shares; 2026Q1: 276,661 shares 276,661 $3.61M 0.22% -2,300 Timeline GLUE MONTE ROSA THERAPEUTICS INC More: the full row for MONTE ROSA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 215,752 shares; 2025Q4: 215,752 shares; 2026Q1: 215,752 shares 215,752 $3.55M 0.21% 0 Timeline ONC BEONE MEDICINES LTD More: the full row for BEONE MEDICINES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 978 shares; 2024Q4: 2,974 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 11,701 shares 11,701 $3.47M 0.21% new Timeline TENX TENAX THERAPEUTICS INC More: the full row for TENAX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 62,423 shares; 2024Q4: 34,693 shares; 2025Q1: 68,741 shares; 2025Q2: 155,557 shares; 2025Q3: 53,428 shares; 2025Q4: 63,673 shares; 2026Q1: 213,462 shares 213,462 $3.41M 0.21% +149,789 Timeline AVBP ARRIVENT BIOPHARMA INC More: the full row for ARRIVENT BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 141,814 shares 141,814 $3.27M 0.2% new Timeline PLRX PLIANT THERAPEUTICS INC More: the full row for PLIANT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 246,128 shares; 2024Q4: 134,798 shares; 2025Q1: not reported; 2025Q2: 82,189 shares; 2025Q3: not reported; 2025Q4: 73,819 shares; 2026Q1: 2,585,126 shares 2,585,126 $3.26M 0.2% +2,511,307 Timeline ATAI ATAIBECKLEY INC More: the full row for ATAIBECKLEY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 913,242 shares 913,242 $3.23M 0.19% new Timeline RLMD RELMADA THERAPEUTICS INC More: the full row for RELMADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 130,000 shares; 2025Q3: not reported; 2025Q4: 30,866 shares; 2026Q1: 451,918 shares 451,918 $3.15M 0.19% +421,052 Timeline CATX PERSPECTIVE THERAPEUTICS INC More: the full row for PERSPECTIVE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 95,193 shares; 2026Q1: 749,335 shares 749,335 $3.12M 0.19% +654,142 Timeline CRBP CORBUS PHARMACEUTICALS HLDGS More: the full row for CORBUS PHARMACEUTICALS HLDGS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,200 shares; 2025Q4: 286,781 shares; 2026Q1: 331,781 shares 331,781 $3.12M 0.19% +45,000 Timeline ELDN ELEDON PHARMACEUTICALS INC More: the full row for ELEDON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 16,000 shares; 2025Q1: 16,600 shares; 2025Q2: 16,900 shares; 2025Q3: not reported; 2025Q4: 1,821,812 shares; 2026Q1: 974,421 shares 974,421 $3M 0.18% -847,391 Timeline PHVS PHARVARIS N V More: the full row for PHARVARIS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 34,124 shares; 2025Q3: 34,124 shares; 2025Q4: 85,528 shares; 2026Q1: 105,528 shares 105,528 $2.98M 0.18% +20,000 Timeline APLS APELLIS PHARMACEUTICALS INC More: the full row for APELLIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 17,252 shares; 2024Q4: 15,000 shares; 2025Q1: 17,000 shares; 2025Q2: 17,000 shares; 2025Q3: 20,000 shares; 2025Q4: 20,000 shares; 2026Q1: 72,500 shares 72,500 $2.92M 0.18% +52,500 Timeline EWTX EDGEWISE THERAPEUTICS INC More: the full row for EDGEWISE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 18,178 shares; 2024Q4: not reported; 2025Q1: 20,000 shares; 2025Q2: 40,000 shares; 2025Q3: 40,000 shares; 2025Q4: 90,999 shares; 2026Q1: 90,599 shares 90,599 $2.85M 0.17% -400 Timeline PEPG PEPGEN INC More: the full row for PEPGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 20,352 shares; 2025Q2: 20,352 shares; 2025Q3: 36,842 shares; 2025Q4: 36,842 shares; 2026Q1: 1,607,638 shares 1,607,638 $2.85M 0.17% +1,570,796 Timeline CAPR CAPRICOR THERAPEUTICS INC More: the full row for CAPRICOR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 24,307 shares; 2024Q4: 56,120 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 90,593 shares 90,593 $2.75M 0.17% new Timeline MASI MASIMO CORP More: the full row for MASIMO CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,894 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 15,000 shares; 2025Q4: 15,000 shares; 2026Q1: 15,000 shares 15,000 $2.67M 0.16% 0 Timeline INO INOVIO PHARMACEUTICALS INC More: the full row for INOVIO PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,485,008 shares; 2026Q1: 1,470,108 shares 1,470,108 $2.56M 0.15% -14,900 Timeline TFX TELEFLEX INCORPORATED More: the full row for TELEFLEX INCORPORATED Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 80,627 shares; 2026Q1: 21,186 shares 21,186 $2.53M 0.15% -59,441 Timeline DRUG BRIGHT MINDS BIOSCIENCES INC More: the full row for BRIGHT MINDS BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 3,500 shares; 2026Q1: 33,900 shares 33,900 $2.47M 0.15% +30,400 Timeline BIOA BIOAGE LABS INC More: the full row for BIOAGE LABS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 123,037 shares; 2025Q1: 971,100 shares; 2025Q2: 1,937,123 shares; 2025Q3: 1,880,073 shares; 2025Q4: 135,560 shares; 2026Q1: 135,560 shares 135,560 $2.37M 0.14% 0 Timeline ALEC ALECTOR INC More: the full row for ALECTOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 428,802 shares; 2024Q4: 368,330 shares; 2025Q1: 380,330 shares; 2025Q2: 1,723,526 shares; 2025Q3: not reported; 2025Q4: 1,108,000 shares; 2026Q1: 1,050,000 shares 1,050,000 $2.26M 0.14% -58,000 Timeline PFE PFIZER INC More: the full row for PFIZER INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 35,950 shares; 2024Q4: 35,050 shares; 2025Q1: 41,050 shares; 2025Q2: 39,400 shares; 2025Q3: 44,400 shares; 2025Q4: 72,400 shares; 2026Q1: 77,400 shares 77,400 $2.17M 0.13% +5,000 Timeline DCTH DELCATH SYS INC More: the full row for DELCATH SYS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 31,052 shares; 2024Q4: 149,385 shares; 2025Q1: 149,385 shares; 2025Q2: 149,385 shares; 2025Q3: 224,385 shares; 2025Q4: 224,385 shares; 2026Q1: 224,385 shares 224,385 $2.08M 0.13% 0 Timeline BIIB BIOGEN INC More: the full row for BIOGEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 29,625 shares; 2024Q4: 3,045 shares; 2025Q1: 4,500 shares; 2025Q2: 5,100 shares; 2025Q3: 18,000 shares; 2025Q4: 24,300 shares; 2026Q1: 11,000 shares 11,000 $2.02M 0.12% -13,300 Timeline CNTB CONNECT BIOPHARMA HLDGS LTD More: the full row for CONNECT BIOPHARMA HLDGS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 742,400 shares 742,400 $1.95M 0.12% new Timeline SMMT SUMMIT THERAPEUTICS INC More: the full row for SUMMIT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 12,000 shares; 2025Q3: 102,969 shares; 2025Q4: 91,869 shares; 2026Q1: 91,869 shares 91,869 $1.74M 0.1% 0 Timeline GMED GLOBUS MED INC More: the full row for GLOBUS MED INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,100 shares; 2026Q1: 20,100 shares 20,100 $1.73M 0.1% 0 Timeline ALKS ALKERMES PLC More: the full row for ALKERMES PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 74,431 shares; 2024Q4: 10,188 shares; 2025Q1: not reported; 2025Q2: 45,000 shares; 2025Q3: 56,200 shares; 2025Q4: 63,700 shares; 2026Q1: 46,400 shares 46,400 $1.64M 0.1% -17,300 Timeline SLNO SOLENO THERAPEUTICS INC More: the full row for SOLENO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: 36,830 shares; 2025Q1: 18,830 shares; 2025Q2: 17,330 shares; 2025Q3: 25,230 shares; 2025Q4: 41,830 shares; 2026Q1: 46,830 shares 46,830 $1.57M 0.09% +5,000 Timeline CCIIU COHEN CIRCLE ACQUISIT CORP I More: the full row for COHEN CIRCLE ACQUISIT CORP I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 150,000 shares; 2025Q4: 150,000 shares; 2026Q1: 150,000 shares 150,000 $1.55M 0.09% 0 Timeline RCKT ROCKET PHARMACEUTICALS INC More: the full row for ROCKET PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 4,300 shares; 2024Q4: 211,400 shares; 2025Q1: 241,800 shares; 2025Q2: 275,800 shares; 2025Q3: 575,800 shares; 2025Q4: 475,800 shares; 2026Q1: 432,500 shares 432,500 $1.55M 0.09% -43,300 Timeline SUPN SUPERNUS PHARMACEUTICALS More: the full row for SUPERNUS PHARMACEUTICALS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 14,418 shares; 2025Q4: 29,742 shares; 2026Q1: 29,642 shares 29,642 $1.53M 0.09% -100 Timeline CNTA CENTESSA PHARMACEUTICALS PLC More: the full row for CENTESSA PHARMACEUTICALS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 23,302 shares; 2024Q4: 154,027 shares; 2025Q1: 216,166 shares; 2025Q2: 296,766 shares; 2025Q3: 53,666 shares; 2025Q4: 38,566 shares; 2026Q1: 38,566 shares 38,566 $1.53M 0.09% 0 Timeline FOLD AMICUS THERAPEUTIC More: the full row for AMICUS THERAPEUTIC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 105,000 shares 105,000 $1.52M 0.09% new Timeline MAZE MAZE THERAPEUTICS INC More: the full row for MAZE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 26,045 shares; 2025Q4: 179,532 shares; 2026Q1: 50,095 shares 50,095 $1.5M 0.09% -129,437 Timeline UNH UNITEDHEALTH GROUP INC More: the full row for UNITEDHEALTH GROUP INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,501 shares 5,501 $1.49M 0.09% new Timeline ADGM ADAGIO MED HLDGS INC More: the full row for ADAGIO MED HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 148,861 shares; 2024Q4: 76,757 shares; 2025Q1: 76,757 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,159,614 shares; 2026Q1: 1,205,447 shares 1,205,447 $1.39M 0.08% +45,833 Timeline FWRD FORWARD AIR CORP More: the full row for FORWARD AIR CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 26,635 shares; 2026Q1: 78,241 shares 78,241 $1.31M 0.08% +51,606 Timeline SXT SENSIENT TECHNOLOGIES CORP More: the full row for SENSIENT TECHNOLOGIES CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 15,000 shares 15,000 $1.3M 0.08% new Timeline KNSA KINIKSA PHARMACEUTICALS INTL More: the full row for KINIKSA PHARMACEUTICALS INTL Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 436,668 shares; 2024Q4: 166,406 shares; 2025Q1: 41,412 shares; 2025Q2: 56,540 shares; 2025Q3: 75,187 shares; 2025Q4: 28,728 shares; 2026Q1: 26,913 shares 26,913 $1.3M 0.08% -1,815 Timeline CRVS CORVUS PHARMACEUTICALS INC More: the full row for CORVUS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 465,875 shares; 2026Q1: 87,901 shares 87,901 $1.29M 0.08% -377,974 Timeline MSLE SATELLOS BIOSCIENCE INC More: the full row for SATELLOS BIOSCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 222,555 shares 222,555 $1.25M 0.08% new Timeline QURE UNIQURE NV More: the full row for UNIQURE NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 10,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 133,316 shares; 2025Q4: 235,155 shares; 2026Q1: 76,206 shares 76,206 $1.25M 0.07% -158,949 Timeline NVO NOVO-NORDISK A S More: the full row for NOVO-NORDISK A S Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 33,000 shares 33,000 $1.21M 0.07% new Timeline PMN PROMIS NEUROSCIENCES INC More: the full row for PROMIS NEUROSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 95,350 shares 95,350 $1.21M 0.07% new Timeline LXRX LEXICON PHARMACEUTICALS INC More: the full row for LEXICON PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 750,000 shares 750,000 $1.17M 0.07% new Timeline SDGR SCHRODINGER INC More: the full row for SCHRODINGER INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 25,147 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 101,500 shares 101,500 $1.15M 0.07% new Timeline XNCR XENCOR INC More: the full row for XENCOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 342,262 shares; 2024Q4: 234,607 shares; 2025Q1: 398,152 shares; 2025Q2: 85,826 shares; 2025Q3: 128,865 shares; 2025Q4: 56,165 shares; 2026Q1: 93,665 shares 93,665 $1.13M 0.07% +37,500 Timeline OABI OMNIAB INC More: the full row for OMNIAB INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,337,302 shares; 2024Q4: 278,108 shares; 2025Q1: 126,108 shares; 2025Q2: 326,108 shares; 2025Q3: 1,090,628 shares; 2025Q4: 702,190 shares; 2026Q1: 705,190 shares 705,190 $1.11M 0.07% +3,000 Timeline FDMT 4D MOLECULAR THERAPEUTICS IN More: the full row for 4D MOLECULAR THERAPEUTICS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 6,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 16,712 shares; 2025Q4: 116,712 shares; 2026Q1: 116,712 shares 116,712 $1.09M 0.07% 0 Timeline KROS KEROS THERAPEUTICS INC More: the full row for KEROS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 445,068 shares; 2024Q4: 23,246 shares; 2025Q1: 1,486,461 shares; 2025Q2: 5,389,264 shares; 2025Q3: 5,389,264 shares; 2025Q4: 18,851 shares; 2026Q1: 97,318 shares 97,318 $1.07M 0.06% +78,467 Timeline DAWN DAY ONE BIOPHARMACEUTICALS I More: the full row for DAY ONE BIOPHARMACEUTICALS I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 53,111 shares; 2024Q4: 53,023 shares; 2025Q1: 28,023 shares; 2025Q2: 28,023 shares; 2025Q3: 28,023 shares; 2025Q4: not reported; 2026Q1: 49,923 shares 49,923 $1.07M 0.06% new Timeline BMY BRISTOL-MYERS SQUIBB CO More: the full row for BRISTOL-MYERS SQUIBB CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 17,500 shares 17,500 $1.06M 0.06% -2,500 Timeline TNGX TANGO THERAPEUTICS INC More: the full row for TANGO THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 41,346 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 140,021 shares; 2026Q1: 50,000 shares 50,000 $1.05M 0.06% -90,021 Timeline TNYA TENAYA THERAPEUTICS INC More: the full row for TENAYA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,505,300 shares; 2026Q1: 1,507,800 shares 1,507,800 $1.04M 0.06% +2,500 Timeline BSAAU BEST SPAC I ACQUISITION CORP More: the full row for BEST SPAC I ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 100,000 shares; 2025Q3: 100,000 shares; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares 100,000 $1.04M 0.06% 0 Timeline MCK MCKESSON CORP More: the full row for MCKESSON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,850 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,200 shares; 2026Q1: 1,200 shares 1,200 $1.04M 0.06% 0 Timeline BMRN BIOMARIN PHARMACEUTICAL INC More: the full row for BIOMARIN PHARMACEUTICAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,200 shares; 2024Q4: not reported; 2025Q1: 4,900 shares; 2025Q2: 4,900 shares; 2025Q3: 4,900 shares; 2025Q4: 12,900 shares; 2026Q1: 18,200 shares 18,200 $1.03M 0.06% +5,300 Timeline ARROWHEAD PHARMACEUTICALS IN ARROWHEAD PHARMACEUTICALS IN More: the full row for ARROWHEAD PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 10,000 shares 10,000 $1.02M 0.06% new ORKA ORUKA THERAPEUTICS INC More: the full row for ORUKA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 11,187 shares; 2024Q4: not reported; 2025Q1: 132,780 shares; 2025Q2: 142,780 shares; 2025Q3: 20,840 shares; 2025Q4: 20,840 shares; 2026Q1: 20,840 shares 20,840 $1.02M 0.06% 0 Timeline EA ELECTRONIC ARTS INC More: the full row for ELECTRONIC ARTS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 4,936 shares; 2025Q4: 4,936 shares; 2026Q1: 4,936 shares 4,936 $1.01M 0.06% 0 Timeline FULC FULCRUM THERAPEUTICS INC More: the full row for FULCRUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 55,802 shares; 2024Q4: 196,248 shares; 2025Q1: 490,532 shares; 2025Q2: 53,349 shares; 2025Q3: 341,612 shares; 2025Q4: 1,253,749 shares; 2026Q1: 130,560 shares 130,560 $1M 0.06% -1,123,189 Timeline BCRX BIOCRYST PHARMACEUTICALS INC More: the full row for BIOCRYST PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 35,000 shares; 2024Q4: 35,000 shares; 2025Q1: 10,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 45,000 shares; 2026Q1: 105,000 shares 105,000 $1000K 0.06% +60,000 Timeline GH GUARDANT HEALTH INC More: the full row for GUARDANT HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 6,000 shares; 2025Q4: 7,000 shares; 2026Q1: 10,000 shares 10,000 $924K 0.06% +3,000 Timeline CBIO CRESCENT BIOPHARMA INC. More: the full row for CRESCENT BIOPHARMA INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 606,000 shares; 2026Q1: 50,273 shares 50,273 $924K 0.06% -555,727 Timeline CNTX CONTEXT THERAPEUTICS INC More: the full row for CONTEXT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 373,835 shares; 2024Q4: 351,094 shares; 2025Q1: 351,094 shares; 2025Q2: 351,094 shares; 2025Q3: 351,094 shares; 2025Q4: 351,094 shares; 2026Q1: 351,094 shares 351,094 $920K 0.06% 0 Timeline ENGN ENGENE HOLDINGS INC More: the full row for ENGENE HOLDINGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,970 shares; 2024Q4: not reported; 2025Q1: 23,799 shares; 2025Q2: 27,787 shares; 2025Q3: not reported; 2025Q4: 303,686 shares; 2026Q1: 133,686 shares 133,686 $910K 0.05% -170,000 Timeline SLN SILENCE THERAPEUTICS PLC More: the full row for SILENCE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 40,290 shares; 2024Q4: 18,000 shares; 2025Q1: 18,643 shares; 2025Q2: 18,643 shares; 2025Q3: 18,643 shares; 2025Q4: 23,643 shares; 2026Q1: 172,157 shares 172,157 $907K 0.05% +148,514 Timeline ARE ALEXANDRIA REAL ESTATE EQ IN More: the full row for ALEXANDRIA REAL ESTATE EQ IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 16,300 shares; 2026Q1: 19,500 shares 19,500 $905K 0.05% +3,200 Timeline IBIO IBIO INC More: the full row for IBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 476,212 shares; 2024Q4: 415,606 shares; 2025Q1: not reported; 2025Q2: 54,819 shares; 2025Q3: 27,000 shares; 2025Q4: 405,531 shares; 2026Q1: 469,878 shares 469,878 $893K 0.05% +64,347 Timeline BNTX BIONTECH SE More: the full row for BIONTECH SE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: not reported; 2025Q1: 5,000 shares; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares 10,000 $889K 0.05% 0 Timeline GILD GILEAD SCIENCES INC More: the full row for GILEAD SCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 6,666 shares; 2026Q1: 6,351 shares 6,351 $885K 0.05% -315 Timeline NRIX NURIX THERAPEUTICS INC More: the full row for NURIX THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 11,000 shares; 2025Q1: 21,200 shares; 2025Q2: 31,200 shares; 2025Q3: 31,200 shares; 2025Q4: 72,070 shares; 2026Q1: 56,070 shares 56,070 $869K 0.05% -16,000 Timeline DYN DYNE THERAPEUTICS INC More: the full row for DYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 400 shares; 2024Q4: not reported; 2025Q1: 30,099 shares; 2025Q2: 23,063 shares; 2025Q3: 37,663 shares; 2025Q4: 42,674 shares; 2026Q1: 47,463 shares 47,463 $861K 0.05% +4,789 Timeline ISRG INTUITIVE SURGICAL INC More: the full row for INTUITIVE SURGICAL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 700 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,020 shares; 2026Q1: 1,830 shares 1,830 $844K 0.05% +810 Timeline ANL ADLAI NORTYE GROUP LTD More: the full row for ADLAI NORTYE GROUP LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 117,909 shares 117,909 $816K 0.05% new Timeline WW WW INTL INC More: the full row for WW INTL INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 52,450 shares; 2025Q4: 57,100 shares; 2026Q1: 57,700 shares 57,700 $793K 0.05% +600 Timeline RNA ATRIUM THERAPEUTICS INC More: the full row for ATRIUM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 57,688 shares 57,688 $771K 0.05% new Timeline ITGR INTEGER HLDGS CORP More: the full row for INTEGER HLDGS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 8,750 shares 8,750 $770K 0.05% new Timeline KPTI KARYOPHARM THERAPEUTICS INC More: the full row for KARYOPHARM THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 25,000 shares; 2025Q4: 50,000 shares; 2026Q1: 136,736 shares 136,736 $762K 0.05% +86,736 Timeline CMPX COMPASS THERAPEUTICS INC More: the full row for COMPASS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 25,000 shares; 2025Q3: 50,000 shares; 2025Q4: 139,000 shares; 2026Q1: 139,000 shares 139,000 $735K 0.04% 0 Timeline NUVL NUVALENT INC More: the full row for NUVALENT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 10,442 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 11,842 shares; 2025Q3: 11,842 shares; 2025Q4: 6,842 shares; 2026Q1: 6,942 shares 6,942 $711K 0.04% +100 Timeline CGEM CULLINAN THERAPEUTICS INC More: the full row for CULLINAN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 54,358 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,000 shares; 2026Q1: 50,000 shares 50,000 $710K 0.04% 0 Timeline IDYA IDEAYA BIOSCIENCES INC More: the full row for IDEAYA BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 20,000 shares; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares 20,000 $666K 0.04% 0 Timeline ENTA ENANTA PHARMACEUTICALS INC More: the full row for ENANTA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 41,357 shares; 2026Q1: 51,357 shares 51,357 $649K 0.04% +10,000 Timeline VERA VERA THERAPEUTICS INC More: the full row for VERA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 14,733 shares; 2026Q1: 16,033 shares 16,033 $645K 0.04% +1,300 Timeline VYNE VYNE THERAPEUTICS INC More: the full row for VYNE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 152,865 shares; 2024Q4: not reported; 2025Q1: 70,419 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 253,791 shares; 2026Q1: 1,063,899 shares 1,063,899 $636K 0.04% +810,108 Timeline BSX BOSTON SCIENTIFIC CORP More: the full row for BOSTON SCIENTIFIC CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,500 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 5,000 shares; 2026Q1: 10,000 shares 10,000 $628K 0.04% +5,000 Timeline AVTR AVANTOR INC More: the full row for AVANTOR INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: 25,000 shares; 2025Q4: 70,000 shares; 2026Q1: 80,000 shares 80,000 $627K 0.04% +10,000 Timeline ARVN ARVINAS INC More: the full row for ARVINAS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 20,400 shares; 2024Q4: not reported; 2025Q1: 313,354 shares; 2025Q2: 128,767 shares; 2025Q3: 82,591 shares; 2025Q4: 58,091 shares; 2026Q1: 57,591 shares 57,591 $610K 0.04% -500 Timeline KZR KEZAR LIFE SCIENCES INC More: the full row for KEZAR LIFE SCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,338,273 shares; 2024Q4: 147,404 shares; 2025Q1: 147,404 shares; 2025Q2: 147,404 shares; 2025Q3: 124,967 shares; 2025Q4: 117,440 shares; 2026Q1: 81,933 shares 81,933 $608K 0.04% -35,507 Timeline KLRS KALARIS THERAPEUTICS INC More: the full row for KALARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,000 shares; 2026Q1: 100,000 shares 100,000 $577K 0.03% 0 Timeline MIRM MIRUM PHARMACEUTICALS INC More: the full row for MIRUM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 24,100 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 6,200 shares 6,200 $573K 0.03% new Timeline JAZZ JAZZ PHARMACEUTICALS PLC More: the full row for JAZZ PHARMACEUTICALS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,750 shares; 2025Q3: 2,500 shares; 2025Q4: 8,000 shares; 2026Q1: 3,000 shares 3,000 $567K 0.03% -5,000 Timeline ASMB ASSEMBLY BIOSCIENCES INC More: the full row for ASSEMBLY BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 18,947 shares; 2025Q4: 19,747 shares; 2026Q1: 19,947 shares 19,947 $554K 0.03% +200 Timeline PRLD PRELUDE THERAPEUTICS INC More: the full row for PRELUDE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 152,825 shares 152,825 $523K 0.03% new Timeline GTERU GLOBA TERRA ACQUISITION COR More: the full row for GLOBA TERRA ACQUISITION COR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 50,000 shares; 2025Q4: 50,000 shares; 2026Q1: 50,000 shares 50,000 $518K 0.03% 0 Timeline USFR WISDOMTREE TR More: the full row for WISDOMTREE TR Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares 10,000 $503K 0.03% 0 Timeline ACRS ACLARIS THERAPEUTICS INC More: the full row for ACLARIS THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 90,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 373,682 shares; 2025Q4: 613,986 shares; 2026Q1: 132,426 shares 132,426 $497K 0.03% -481,560 Timeline PRAX PRAXIS PRECISION MEDICINES I More: the full row for PRAXIS PRECISION MEDICINES I Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,500 shares; 2026Q1: 1,500 shares 1,500 $483K 0.03% 0 Timeline LUNG PULMONX CORP More: the full row for PULMONX CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 28,221 shares; 2025Q1: not reported; 2025Q2: 204,497 shares; 2025Q3: 214,497 shares; 2025Q4: 355,410 shares; 2026Q1: 374,497 shares 374,497 $483K 0.03% +19,087 Timeline ELAN ELANCO ANIMAL HEALTH INC More: the full row for ELANCO ANIMAL HEALTH INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares 20,000 $479K 0.03% 0 Timeline PHAT PHATHOM PHARMACEUTICALS INC More: the full row for PHATHOM PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 200 shares; 2024Q4: 55,400 shares; 2025Q1: 42,800 shares; 2025Q2: 63,424 shares; 2025Q3: 42,900 shares; 2025Q4: 42,900 shares; 2026Q1: 42,900 shares 42,900 $477K 0.03% 0 Timeline MDGL MADRIGAL PHARMACEUTICALS INC More: the full row for MADRIGAL PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 50 shares; 2024Q4: not reported; 2025Q1: 1,490 shares; 2025Q2: 1,054 shares; 2025Q3: 4,895 shares; 2025Q4: 895 shares; 2026Q1: 895 shares 895 $469K 0.03% 0 Timeline PYPD POLYPID LTD More: the full row for POLYPID LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 93,902 shares; 2024Q4: 80,080 shares; 2025Q1: 80,080 shares; 2025Q2: 103,950 shares; 2025Q3: not reported; 2025Q4: 103,950 shares; 2026Q1: 103,950 shares 103,950 $455K 0.03% 0 Timeline BABA ALIBABA GROUP HLDG LTD More: the full row for ALIBABA GROUP HLDG LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 3,578 shares; 2025Q4: 3,578 shares; 2026Q1: 3,578 shares 3,578 $449K 0.03% 0 Timeline CORZ CORE SCIENTIFIC INC NEW More: the full row for CORE SCIENTIFIC INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 30,000 shares 30,000 $449K 0.03% 0 Timeline WHWK WHITEHAWK THERAPEUTICS INC More: the full row for WHITEHAWK THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 77,593 shares; 2026Q1: 128,503 shares 128,503 $443K 0.03% +50,910 Timeline NTRA NATERA INC More: the full row for NATERA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 4,250 shares; 2025Q2: 2,500 shares; 2025Q3: not reported; 2025Q4: 2,147 shares; 2026Q1: 2,147 shares 2,147 $429K 0.03% 0 Timeline VTGN VISTAGEN THERAPEUTICS INC More: the full row for VISTAGEN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 163,078 shares; 2024Q4: 121,461 shares; 2025Q1: 420,765 shares; 2025Q2: 420,765 shares; 2025Q3: 113,062 shares; 2025Q4: 623,575 shares; 2026Q1: 751,141 shares 751,141 $429K 0.03% +127,566 Timeline TXMD THERAPEUTICSMD INC More: the full row for THERAPEUTICSMD INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 270,160 shares; 2024Q4: 270,160 shares; 2025Q1: 270,160 shares; 2025Q2: 209,210 shares; 2025Q3: 209,210 shares; 2025Q4: 209,210 shares; 2026Q1: 209,210 shares 209,210 $423K 0.03% 0 Timeline SNDX SYNDAX PHARMACEUTICALS INC More: the full row for SYNDAX PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 350,206 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,000 shares; 2025Q3: not reported; 2025Q4: 12,000 shares; 2026Q1: 17,500 shares 17,500 $409K 0.02% +5,500 Timeline TECX TECTONIC THERAPEUTIC INC More: the full row for TECTONIC THERAPEUTIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 127,159 shares; 2024Q4: 58,708 shares; 2025Q1: 62,603 shares; 2025Q2: 73,505 shares; 2025Q3: 56,007 shares; 2025Q4: 30,007 shares; 2026Q1: 13,001 shares 13,001 $402K 0.02% -17,006 Timeline TRDA ENTRADA THERAPEUTICS INC More: the full row for ENTRADA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 30,500 shares 30,500 $385K 0.02% new Timeline BHVN BIOHAVEN LTD More: the full row for BIOHAVEN LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 2,637 shares; 2024Q4: not reported; 2025Q1: 22,641 shares; 2025Q2: 32,341 shares; 2025Q3: 24,341 shares; 2025Q4: 34,277 shares; 2026Q1: 44,777 shares 44,777 $379K 0.02% +10,500 Timeline MRK MERCK & CO INC More: the full row for MERCK & CO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,140 shares; 2024Q4: 2,440 shares; 2025Q1: not reported; 2025Q2: 7,040 shares; 2025Q3: 18,540 shares; 2025Q4: 9,640 shares; 2026Q1: 3,140 shares 3,140 $378K 0.02% -6,500 Timeline VSTM VERASTEM INC More: the full row for VERASTEM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 71,100 shares 71,100 $377K 0.02% new Timeline RGNX REGENXBIO INC More: the full row for REGENXBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 569,008 shares; 2024Q4: 170,129 shares; 2025Q1: 350,352 shares; 2025Q2: 207,818 shares; 2025Q3: 205,409 shares; 2025Q4: 144,848 shares; 2026Q1: 44,416 shares 44,416 $372K 0.02% -100,432 Timeline ACET ADICET BIO INC More: the full row for ADICET BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 128,646 shares; 2026Q1: 53,827 shares 53,827 $367K 0.02% -74,819 Timeline LEGN LEGEND BIOTECH CORP More: the full row for LEGEND BIOTECH CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,000 shares 20,000 $362K 0.02% new Timeline SRZN SURROZEN INC More: the full row for SURROZEN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 12,000 shares 12,000 $350K 0.02% new Timeline ZNTL ZENTALIS PHARMACEUTICALS INC More: the full row for ZENTALIS PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 50,000 shares; 2025Q3: 50,000 shares; 2025Q4: 80,000 shares; 2026Q1: 144,636 shares 144,636 $338K 0.02% +64,636 Timeline BCYC BICYCLE THERAPEUTICS PLC More: the full row for BICYCLE THERAPEUTICS PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 71,298 shares 71,298 $331K 0.02% new Timeline NBIX NEUROCRINE BIOSCIENCES INC More: the full row for NEUROCRINE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 2,500 shares 2,500 $329K 0.02% new Timeline WVE WAVE LIFE SCIENCES LTD More: the full row for WAVE LIFE SCIENCES LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 21,700 shares; 2025Q1: 23,100 shares; 2025Q2: 114,814 shares; 2025Q3: 119,067 shares; 2025Q4: not reported; 2026Q1: 44,900 shares 44,900 $326K 0.02% new Timeline KURA KURA ONCOLOGY INC More: the full row for KURA ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 30,000 shares; 2024Q4: not reported; 2025Q1: 25,000 shares; 2025Q2: 34,300 shares; 2025Q3: 55,000 shares; 2025Q4: 40,000 shares; 2026Q1: 40,000 shares 40,000 $325K 0.02% 0 Timeline KPRX KIORA PHARMACEUTICALS INC More: the full row for KIORA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 196,551 shares; 2024Q4: 200,221 shares; 2025Q1: 194,665 shares; 2025Q2: 167,111 shares; 2025Q3: 167,941 shares; 2025Q4: 167,941 shares; 2026Q1: 167,941 shares 167,941 $324K 0.02% 0 Timeline CORT CORCEPT THERAPEUTICS INC More: the full row for CORCEPT THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 8,000 shares 8,000 $322K 0.02% new Timeline UPB UPSTREAM BIO INC More: the full row for UPSTREAM BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 15,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 35,000 shares 35,000 $315K 0.02% new Timeline KIDS ORTHOPEDIATRICS CORP More: the full row for ORTHOPEDIATRICS CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 19,845 shares; 2026Q1: 19,845 shares 19,845 $315K 0.02% 0 Timeline ANNX ANNEXON INC More: the full row for ANNEXON INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 48,000 shares; 2026Q1: 55,000 shares 55,000 $305K 0.02% +7,000 Timeline GERN GERON CORP More: the full row for GERON CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 557,159 shares; 2024Q4: 337,676 shares; 2025Q1: 266,176 shares; 2025Q2: 441,176 shares; 2025Q3: 456,176 shares; 2025Q4: 336,176 shares; 2026Q1: 200,000 shares 200,000 $298K 0.02% -136,176 Timeline JD JD.COM INC More: the full row for JD.COM INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares 10,000 $296K 0.02% 0 Timeline PMVP PMV PHARMACEUTICALS INC More: the full row for PMV PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 101,008 shares; 2024Q4: 101,008 shares; 2025Q1: 101,008 shares; 2025Q2: 101,008 shares; 2025Q3: 101,008 shares; 2025Q4: 101,008 shares; 2026Q1: 231,008 shares 231,008 $286K 0.02% +130,000 Timeline TRAW TRAWS PHARMA INC More: the full row for TRAWS PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 154,431 shares; 2026Q1: 154,098 shares 154,098 $282K 0.02% -333 Timeline JBIO JADE BIOSCIENCES INC More: the full row for JADE BIOSCIENCES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 21,000 shares; 2026Q1: 20,000 shares 20,000 $281K 0.02% -1,000 Timeline RARE ULTRAGENYX PHARMACEUTICAL IN More: the full row for ULTRAGENYX PHARMACEUTICAL IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 8,000 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 9,000 shares; 2025Q4: not reported; 2026Q1: 13,400 shares 13,400 $281K 0.02% new Timeline PROCAP ACQUISITION CORP PROCAP ACQUISITION CORP More: the full row for PROCAP ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,680 shares; 2025Q3: 26,940 shares; 2025Q4: 26,940 shares; 2026Q1: 26,940 shares 26,940 $279K 0.02% 0 BCAX BICARA THERAPEUTICS INC More: the full row for BICARA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 40,440 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,875 shares; 2025Q3: 13,705 shares; 2025Q4: 13,705 shares; 2026Q1: 13,705 shares 13,705 $273K 0.02% 0 Timeline RXST RXSIGHT INC More: the full row for RXSIGHT INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 21,803 shares; 2026Q1: 43,250 shares 43,250 $266K 0.02% +21,447 Timeline PANW PALO ALTO NETWORKS INC More: the full row for PALO ALTO NETWORKS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,600 shares 1,600 $257K 0.02% new Timeline NTLA INTELLIA THERAPEUTICS INC More: the full row for INTELLIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 800 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 19,517 shares 19,517 $250K 0.02% new Timeline CRWD CROWDSTRIKE HLDGS INC More: the full row for CROWDSTRIKE HLDGS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 640 shares 640 $250K 0.02% new Timeline RBRK RUBRIK INC. More: the full row for RUBRIK INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,900 shares 4,900 $240K 0.01% new Timeline RPRX ROYALTY PHARMA PLC More: the full row for ROYALTY PHARMA PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,096,666 shares; 2024Q4: 49,963 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 5,000 shares 5,000 $240K 0.01% new Timeline SGRY SURGERY PARTNERS INC More: the full row for SURGERY PARTNERS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 40,000 shares; 2025Q2: 40,000 shares; 2025Q3: 20,000 shares; 2025Q4: 20,000 shares; 2026Q1: 20,000 shares 20,000 $238K 0.01% 0 Timeline LRMR LARIMAR THERAPEUTICS INC More: the full row for LARIMAR THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 237,605 shares; 2025Q3: 235,689 shares; 2025Q4: 185,689 shares; 2026Q1: 52,745 shares 52,745 $237K 0.01% -132,944 Timeline EOLS EVOLUS INC More: the full row for EVOLUS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,859 shares; 2026Q1: 55,859 shares 55,859 $230K 0.01% +20,000 Timeline QTTB Q32 BIO INC More: the full row for Q32 BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 64,245 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 20,000 shares; 2026Q1: 35,000 shares 35,000 $225K 0.01% +15,000 Timeline LGVN LONGEVERON INC More: the full row for LONGEVERON INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 200,000 shares 200,000 $208K 0.01% new Timeline ANAB ANAPTYSBIO INC More: the full row for ANAPTYSBIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 192,720 shares; 2024Q4: 27,301 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 3,698 shares 3,698 $205K 0.01% new Timeline CEPS CANTOR EQUITY PARTNERS VI IN More: the full row for CANTOR EQUITY PARTNERS VI IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,000 shares 20,000 $202K 0.01% new Timeline KALV KALVISTA PHARMACEUTICALS INC More: the full row for KALVISTA PHARMACEUTICALS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 14,143 shares; 2024Q4: 35,843 shares; 2025Q1: 35,743 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares 10,000 $201K 0.01% 0 Timeline KYTX KYVERNA THERAPEUTICS INC More: the full row for KYVERNA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 57,428 shares; 2026Q1: 22,428 shares 22,428 $194K 0.01% -35,000 Timeline NUVB NUVATION BIO INC More: the full row for NUVATION BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 43,500 shares 43,500 $187K 0.01% new Timeline BNTC BENITEC BIOPHARMA INC More: the full row for BENITEC BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 17,500 shares 17,500 $186K 0.01% new Timeline LPCN LIPOCINE INC NEW More: the full row for LIPOCINE INC NEW Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 23,180 shares 23,180 $185K 0.01% new Timeline RLYB RALLYBIO CORP More: the full row for RALLYBIO CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 20,535 shares 20,535 $184K 0.01% new Timeline RZLT REZOLUTE INC More: the full row for REZOLUTE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 1,571,705 shares; 2024Q4: 1,359,208 shares; 2025Q1: 1,116,047 shares; 2025Q2: 989,297 shares; 2025Q3: 815,975 shares; 2025Q4: 38,679 shares; 2026Q1: 58,679 shares 58,679 $179K 0.01% +20,000 Timeline QCLS Q/C TECHNOLOGIES INC More: the full row for Q/C TECHNOLOGIES INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 50,000 shares 50,000 $172K 0.01% new Timeline ERAS ERASCA INC More: the full row for ERASCA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 10,000 shares 10,000 $162K 0.01% new Timeline COYA COYA THERAPEUTICS INC More: the full row for COYA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,900 shares 40,900 $161K 0.01% new Timeline PSNL PERSONALIS INC More: the full row for PERSONALIS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 25,000 shares 25,000 $159K 0.01% new Timeline SIBN SI BONE INC More: the full row for SI BONE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 12,580 shares 12,580 $159K 0.01% new Timeline STLN STARLING ONCOLOGY INC More: the full row for STARLING ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 50,000 shares 50,000 $154K 0.01% new Timeline HELP CYBIN INC More: the full row for CYBIN INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 33,278 shares; 2025Q4: 238,390 shares; 2026Q1: 31,278 shares 31,278 $150K 0.01% -207,112 Timeline STIM NEURONETICS INC More: the full row for NEURONETICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 100,000 shares 100,000 $145K 0.01% new Timeline ARDX ARDELYX INC More: the full row for ARDELYX INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 6,400 shares; 2024Q4: 31,035 shares; 2025Q1: 490,743 shares; 2025Q2: 915,130 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 23,900 shares 23,900 $143K 0.01% new Timeline IFRX INFLARX NV More: the full row for INFLARX NV Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 159,479 shares; 2025Q4: not reported; 2026Q1: 158,271 shares 158,271 $142K 0.01% new Timeline ACHV ACHIEVE LIFE SCIENCE INC More: the full row for ACHIEVE LIFE SCIENCE INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 91 shares; 2024Q4: 13,173 shares; 2025Q1: 43,173 shares; 2025Q2: 43,173 shares; 2025Q3: 47,800 shares; 2025Q4: 47,800 shares; 2026Q1: 47,800 shares 47,800 $141K 0.01% 0 Timeline VYGR VOYAGER THERAPEUTICS INC More: the full row for VOYAGER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 40,634 shares; 2024Q4: 126,792 shares; 2025Q1: 75,545 shares; 2025Q2: 79,945 shares; 2025Q3: 35,000 shares; 2025Q4: 35,000 shares; 2026Q1: 35,000 shares 35,000 $135K 0.01% 0 Timeline CMMB CHEMOMAB THERAPEUTICS LTD More: the full row for CHEMOMAB THERAPEUTICS LTD Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 80,000 shares; 2026Q1: 80,000 shares 80,000 $126K 0.01% 0 Timeline JSPR JASPER THERAPEUTICS INC More: the full row for JASPER THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 15,816 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 140,000 shares; 2026Q1: 140,000 shares 140,000 $123K 0.01% 0 Timeline NEUP NEUPHORIA THERAPEUTICS INC More: the full row for NEUPHORIA THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 30,000 shares; 2026Q1: 30,000 shares 30,000 $122K 0.01% 0 Timeline MIST MILESTONE PHARMACEUTICALS IN More: the full row for MILESTONE PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 27,931 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 100,100 shares; 2026Q1: 100,000 shares 100,000 $119K 0.01% -100 Timeline ARCT ARCTURUS THERAPEUTICS HLDGS More: the full row for ARCTURUS THERAPEUTICS HLDGS Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 15,000 shares 15,000 $116K 0.01% new Timeline MGNX MACROGENICS INC More: the full row for MACROGENICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 40,000 shares 40,000 $116K 0.01% new Timeline CCCC C4 THERAPEUTICS INC More: the full row for C4 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 43,000 shares 43,000 $113K 0.01% new Timeline RXRX RECURSION PHARMACEUTICALS IN More: the full row for RECURSION PHARMACEUTICALS IN Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 15,000 shares; 2024Q4: 15,000 shares; 2025Q1: 15,000 shares; 2025Q2: 35,000 shares; 2025Q3: 35,000 shares; 2025Q4: 35,000 shares; 2026Q1: 35,000 shares 35,000 $107K 0.01% 0 Timeline DSGN DESIGN THERAPEUTICS INC More: the full row for DESIGN THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 42,408 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 10,000 shares 10,000 $106K 0.01% new Timeline GOSS GOSSAMER BIO INC More: the full row for GOSSAMER BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 416,958 shares; 2024Q4: 295,613 shares; 2025Q1: 227,228 shares; 2025Q2: 227,228 shares; 2025Q3: 212,531 shares; 2025Q4: 212,531 shares; 2026Q1: 287,531 shares 287,531 $94.5K 0.01% +75,000 Timeline IMMX IMMIX BIOPHARMA INC More: the full row for IMMIX BIOPHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,000 shares; 2026Q1: 10,000 shares 10,000 $91.1K 0.01% -40,000 Timeline LITS LITE STRATEGY INC More: the full row for LITE STRATEGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 292,397 shares; 2025Q4: 67,292 shares; 2026Q1: 67,292 shares 67,292 $78.1K <0.01% 0 Timeline VERU VERU INC More: the full row for VERU INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 35,000 shares; 2026Q1: 35,000 shares 35,000 $77.3K <0.01% 0 Timeline KYNB KYNTRA BIO INC More: the full row for KYNTRA BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 10,469 shares; 2026Q1: 10,469 shares 10,469 $71K <0.01% 0 Timeline CLOV CLOVER HEALTH INVESTMENTS CO More: the full row for CLOVER HEALTH INVESTMENTS CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 23,300 shares; 2025Q1: 28,300 shares; 2025Q2: 48,300 shares; 2025Q3: 48,300 shares; 2025Q4: 48,300 shares; 2026Q1: 40,000 shares 40,000 $70.4K <0.01% -8,300 Timeline BMEA BIOMEA FUSION INC More: the full row for BIOMEA FUSION INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 43,420 shares; 2026Q1: 43,420 shares 43,420 $66.4K <0.01% 0 Timeline NMRA NEUMORA THERAPEUTICS INC. More: the full row for NEUMORA THERAPEUTICS INC. Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 68,608 shares; 2025Q1: 26,108 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,600 shares; 2026Q1: 33,100 shares 33,100 $64.5K <0.01% -17,500 Timeline OGN ORGANON & CO More: the full row for ORGANON & CO Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 3,100 shares; 2024Q4: 40,200 shares; 2025Q1: 10,000 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 35,000 shares; 2026Q1: 10,000 shares 10,000 $59.9K <0.01% -25,000 Timeline ESPR ESPERION THERAPEUTICS INC NE More: the full row for ESPERION THERAPEUTICS INC NE Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 21,400 shares 21,400 $58.6K <0.01% new Timeline MREO MEREO BIOPHARMA GROUP PLC More: the full row for MEREO BIOPHARMA GROUP PLC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 10,000 shares; 2024Q4: 10,000 shares; 2025Q1: 10,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 150,000 shares; 2026Q1: 150,000 shares 150,000 $49.5K <0.01% 0 Timeline ANTX AN2 THERAPEUTICS INC More: the full row for AN2 THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 13,861 shares 13,861 $47.4K <0.01% new Timeline ASPCR A SPAC III ACQUISITION CORP More: the full row for A SPAC III ACQUISITION CORP Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 215,000 shares; 2025Q2: 215,000 shares; 2025Q3: 215,000 shares; 2025Q4: 215,000 shares; 2026Q1: 215,000 shares 215,000 $42.4K <0.01% 0 Timeline AQST AQUESTIVE THERAPEUTICS INC More: the full row for AQUESTIVE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 10,000 shares 10,000 $41.5K <0.01% new Timeline ATYR ATYR PHARMA INC More: the full row for ATYR PHARMA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 175,000 shares; 2025Q4: 50,685 shares; 2026Q1: 50,685 shares 50,685 $39.5K <0.01% 0 Timeline BCAB BIOATLA INC More: the full row for BIOATLA INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 170,506 shares; 2025Q3: not reported; 2025Q4: 183,107 shares; 2026Q1: 228,107 shares 228,107 $36.7K <0.01% +45,000 Timeline KALA KALA BIO INC More: the full row for KALA BIO INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 306,067 shares; 2024Q4: 220,373 shares; 2025Q1: 298,955 shares; 2025Q2: 149,830 shares; 2025Q3: 141,995 shares; 2025Q4: 141,480 shares; 2026Q1: 141,480 shares 141,480 $24.5K <0.01% 0 Timeline CHRS COHERUS ONCOLOGY INC More: the full row for COHERUS ONCOLOGY INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,366 shares; 2025Q3: 10,366 shares; 2025Q4: 10,366 shares; 2026Q1: 10,366 shares 10,366 $17.5K <0.01% 0 Timeline PRQR PROQR THRAPEUTICS N V More: the full row for PROQR THRAPEUTICS N V Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 20,394 shares; 2025Q1: 20,394 shares; 2025Q2: 10,000 shares; 2025Q3: 10,000 shares; 2025Q4: 10,000 shares; 2026Q1: 10,000 shares 10,000 $16.2K <0.01% 0 Timeline QNCX QUINCE THERAPEUTICS INC More: the full row for QUINCE THERAPEUTICS INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: 142,958 shares; 2024Q4: 142,958 shares; 2025Q1: 142,958 shares; 2025Q2: 142,958 shares; 2025Q3: 775,034 shares; 2025Q4: 42,912 shares; 2026Q1: 50,100 shares 50,100 $5.08K <0.01% +7,188 Timeline IMUX IMMUNIC INC More: the full row for IMMUNIC INC Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 30,000 shares 30,000 $0 0% new Value filed as zero, left out of ratios. Timeline